» Articles » PMID: 17380062

Pathogenesis and Classification of Proliferative Diabetic Vitreoretinopathy

Overview
Journal Ophthalmologica
Publisher Karger
Specialty Ophthalmology
Date 2007 Mar 24
PMID 17380062
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To review the current knowledge regarding the pathogenesis of proliferative diabetic vitreoretinopathy (PDVR) and to present recommendations for its clinical staging.

Design: Focused literature review and authors' clinical experience.

Results: Although several biochemical mediators may be responsible for the pathogenesis of PDVR, no common biochemical pathway exists. Of those mediators, vascular endothelial growth factor is the one most studied so far. However, since in proliferative diabetic retinopathy (PDR) the thickened posterior vitreous cortex is one of the main factors in the development of proliferations, a consequent shrinkage of the posterior vitreous cortex leads to hemorrhages and tractive retinal detachments. Therefore, PDR should be called PDVR. In consequence, the authors present a new morphological classification of PDVR.

Conclusions: There is no consensus about the biochemical pathway responsible for the progression of PDVR. Although several classifications are described in the literature, the classification suggested here is important in the judgment of, the communication about and the therapy of diabetic retinopathy. Furthermore, it is the only reliable classification for predicting the surgical outcome in diabetics.

Citing Articles

Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage.

Yuan M, Hoyek S, Kim L, Chaaya C, Patel N J Vitreoretin Dis. 2024; :24741264241297684.

PMID: 39544710 PMC: 11558646. DOI: 10.1177/24741264241297684.


Chronic ocular small vessel disease: An overview of diabetic retinopathy and its relationship with cardiovascular health.

Iyer S, Radhakrishnan N, Roohipourmoallai R, Guerin C, Maylath J, Garson N Am Heart J Plus. 2024; 29:100270.

PMID: 38510674 PMC: 10945896. DOI: 10.1016/j.ahjo.2023.100270.


Clinical Outcomes of 27-Gauge Pars Plana Vitrectomy for Diabetic Tractional Retinal Detachment Repair.

Duong R, Cai X, Ambati N, Shildkrot Y J Vitreoretin Dis. 2023; 7(4):281-289.

PMID: 37927313 PMC: 10621701. DOI: 10.1177/24741264231169145.


Effect of ILM Peeling on Anatomical and Visual Outcomes in Diabetic Tractional Retinal Detachment.

Pehlivanoglu S, Bektasoglu D, Ozcaliskan S, Alagoz C, Erdogan G, Artunay O Beyoglu Eye J. 2023; 8(3):184-192.

PMID: 37766768 PMC: 10521131. DOI: 10.14744/bej.2023.26986.


Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy.

Crispin M, Gerhart J, Heffer A, Martin M, Abdalla F, Bravo-Nuevo A Invest Ophthalmol Vis Sci. 2023; 64(2):1.

PMID: 36723927 PMC: 9904330. DOI: 10.1167/iovs.64.2.1.